The SHR is a hypertensive animal model and to determine if any neuroprotective effect of IRAP inhibition was secondary to hypertension management, systolic blood pressure was assessed via tail cuff prior to stroke and at 72 h post-stroke. The gene discussed is LNPEP; the disease is hypertensive disorder.